Data / Drug companies / SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited: 46 products in the FDA NDC directory, labeler code 67835
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
SMS Pharmaceuticals Limited (labeler code 67835) lists 46 products in the FDA National Drug Code Directory. By type: 46 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 15, 2024.
The request: Watch SMS Pharmaceuticals Limited (FDA labeler code 67835): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67835
- Products in commercial distribution
- 46
- Packages
- 398
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- February 13, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 46 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Escitalopram oxalate | 67835-0039 | Powder | Bulk ingredients | July 15, 2024 |
| Tadalafil | 67835-0030 | Powder | Bulk ingredients | June 14, 2024 |
| Sildenafil citrate | 67835-0037 | Powder | Bulk ingredients | June 13, 2024 |
| Deferasirox | 67835-0036 | Powder | Bulk ingredients | June 12, 2024 |
| Sodium gluconate | 67835-0035 | Powder | Bulk ingredients | June 12, 2024 |
| Nirmatrelvir | 67835-0034 | Powder | Bulk ingredients | June 12, 2024 |
| Dexibuprofen | 67835-0033 | Powder | Bulk ingredients | June 12, 2024 |
| Ibuprofen sodium dihydrate | 67835-0032 | Powder | Bulk ingredients | June 12, 2024 |
| Ibuprofen arginine | 67835-0031 | Powder | Bulk ingredients | June 12, 2024 |
| Molnupiravir | 67835-0038 | Powder | Bulk ingredients | May 31, 2024 |
| Fenoprofen calcium | 67835-0029 | Powder | Bulk ingredients | September 17, 2021 |
| Clozapine | 67835-0028 | Powder | Bulk ingredients | September 17, 2021 |
| Hydroxychloroquine sulfate | 67835-0027 | Powder | Bulk ingredients | September 17, 2021 |
| Sitagliptin hydrochloride | 67835-0025 | Powder | Bulk ingredients | September 17, 2021 |
| Empagliflozin | 67835-0024 | Powder | Bulk ingredients | September 17, 2021 |
| Dapagliflozin propanediol | 67835-0023 | Powder | Bulk ingredients | September 17, 2021 |
| Perampanel | 67835-0026 | Powder | Bulk ingredients | September 16, 2021 |
| Sitagliptin phosphate | 67835-0022 | Powder | Bulk ingredients | September 16, 2021 |
| Famotidine | 67835-0021 | Powder | Bulk ingredients | June 1, 2020 |
| Tenofovir disoproxil fumarate | 67835-0020 | Powder | Bulk ingredients | November 1, 2019 |
| Ibuprofen | 67835-0019 | Powder | Bulk ingredients | November 1, 2019 |
| Solifenacin succinate | 67835-0018 | Powder | Bulk ingredients | November 1, 2019 |
| Lamivudine | 67835-0017 | Powder | Bulk ingredients | November 1, 2019 |
| Lamotrigine | 67835-0016 | Powder | Bulk ingredients | November 1, 2019 |
| Apixaban | 67835-0015 | Powder | Bulk ingredients | January 25, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.